HealthLynked Corp. Files 8-K for Material Agreement

TL;DR

HealthLynked Corp. signed a big deal on 9/19, creating new financial obligations.

AI Summary

On September 19, 2024, HealthLynked Corp. entered into a material definitive agreement, which also created a direct financial obligation. The company, incorporated in Nevada, filed a Form 8-K to report these events. The principal executive offices are located at 1265 Creekside Parkway, Suite 302, Naples, FL 34108.

Why It Matters

This filing indicates HealthLynked Corp. has entered into a significant agreement that may impact its financial obligations and future operations.

Risk Assessment

Risk Level: medium — Entering into material definitive agreements and creating financial obligations can introduce financial and operational risks for a company.

Key Players & Entities

• HealthLynked Corp. (company) — Registrant
• September 19, 2024 (date) — Date of earliest event reported
• Nevada (jurisdiction) — State of incorporation
• 1265 Creekside Parkway, Suite 302, Naples, FL 34108 (address) — Principal executive offices

FAQ

Key Financial Figures

• $900,000 — te in the aggregate principal amount of $900,000 (the " Notes ") and issued a warrant to
• $0.0001 — 9,258 shares of common stock, par value $0.0001 per share (the " Common Stock "), of th
• $855,000 — lting in net proceeds to the Company of $855,000, which was advanced to the Company in i
• $0.0486 — Common Stock under each of the Notes is $0.0486. The Warrant has an exercise price of

Filing Documents

• ea0215152-8k_health.htm (8-K) — 57KB
• ea021515201ex4-1_health.htm (EX-4.1) — 79KB
• ea021515201ex10-1_health.htm (EX-10.1) — 64KB
• ea021515201ex10-2_health.htm (EX-10.2) — 91KB
• ea021515201ex10-3_health.htm (EX-10.3) — 44KB
• ea021515201ex10-4_health.htm (EX-10.4) — 44KB
• ea021515201ex10-5_health.htm (EX-10.5) — 44KB
• ea021515201ex10-6_health.htm (EX-10.6) — 44KB
• ea021515201ex10-7_health.htm (EX-10.7) — 44KB
• ea021515201ex10-8_health.htm (EX-10.8) — 44KB
• ea021515201ex10-9_health.htm (EX-10.9) — 44KB
• ea021515201ex10-10_health.htm (EX-10.10) — 44KB
• ea021515201ex10-11_health.htm (EX-10.11) — 44KB
• ea021515201ex10-12_health.htm (EX-10.12) — 44KB
• 0001213900-24-081421.txt ( ) — 1064KB
• hlyk-20240919.xsd (EX-101.SCH) — 3KB
• hlyk-20240919_lab.xml (EX-101.LAB) — 33KB
• hlyk-20240919_pre.xml (EX-101.PRE) — 22KB
• ea0215152-8k_health_htm.xml (XML) — 3KB

02

Item 3.02 Unregistered Sales of Equity Securities. On September 19, 2024, HealthLynked Corp., a Nevada corporation (the " Company ") issued and sold ten separate senior secured convertible promissory note in the aggregate principal amount of $900,000 (the " Notes ") and issued a warrant to purchase 9,259,258 shares of common stock, par value $0.0001 per share (the " Common Stock "), of the Company (the " Warrant ") to the Mary S. Dent Gifting Trust (the " Purchaser ") pursuant to a note and warrant purchase agreement between the Company and the Purchaser dated September 19, 2024 (the " Purchase Agreement "). The Purchaser is controlled by the Chief Executive Officer and Chairman of the Company, Dr. Michael Dent. The Company's obligations under the Note are secured by a first priority lien on all of the assets of the Company pursuant to that certain security agreement between the Company and the Purchaser dated September 19, 2024 (the " Security Agreement "). The Notes were issued with an original issue discount of 5%, resulting in net proceeds to the Company of $855,000, which was advanced to the Company in installments between July 10, 2024 and September 10, 2024 as follows: Cash Original Note Advance Maturity Amount Issue Note Note # Date Date Date Advanced Discount Principal 1 09/18/24 07/10/24 01/10/25 $ 35,000.00 $ 1,842.11 $ 36,842.11 2 09/18/24 07/16/24 01/16/25 10,000.00 526.32 10,526.32 3 09/18/24 07/16/24 01/16/25 70,000.00 3,684.21 73,684.21 4 09/18/24 07/19/24 01/19/25 20,000.00 1,052.63 21,052.63 5 09/18/24 07/30/24 01/30/25 100,000.00 5,263.16 105,263.16 6 09/18/24 08/14/24 02/14/25 120,000.00 6,315.79 126,315.79 7 09/18/24 08/20/24 02/20/25 100,000.00 5,263.16 105,263.16 8 09/18/24 08/28/24 02/28/25 50,000.00 2,631.58 52,631.58 9 09/18/24 09/04/24 03/04/25 150,000.00 7,894.74 157,894.74 10 09/18/24 09/10/24 03/10/25 200,000.00 10,526.32 210,526.32

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHLYNKED CORP. Date: September 24, 2024 /s/ David Rosal David Rosal Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR